Physician profile
Wendy Davis
NPI 1962488288
$7,152.83
in general payments reported to CMS, 2019-2025
14 companies · $6,669 in 2025
The $6,669 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $12.97 · 2023: $17.74 · 2025: $6,669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,634 · Food and Beverage: $52.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,634.46 |
| Food and Beverage | $52.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,668.75 | 2025 | |
| Baxter Healthcare | $120.05 | 2019 | |
| Ethicon US, LLC | $113.46 | 2019 | |
| Allergan, INC. | $70.38 | 2019-2020 | |
| Shire North American Group INC | $47.97 | 2019 | |
| Abbvie INC. | $17.74 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.07 | 2019 | |
| Celgene Corporation | $15.83 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.89 | 2019 | |
| Tactile Systems Technology INC | $14.63 | 2019 | |
| Genzyme Corporation | $13.79 | 2019 | |
| Tela Bio, INC. | $13.62 | 2019 | |
| Acell, INC. | $13.51 | 2019 | |
| Merck Sharp & Dohme LLC | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.